These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7291279)

  • 1. Pharmacological study of new indole derivatives and its biochemical correlates.
    Sharma M; Gujrati V; Nath C; Gupta GP; Bhargava KP; Shanker K
    Pharmacol Res Commun; 1981 May; 13(5):461-74. PubMed ID: 7291279
    [No Abstract]   [Full Text] [Related]  

  • 2. 5,8-dihydroharman derivatives. Their preparation and biological activities.
    Remers WA; Greenblatt EN; Ellenbogen L; Weiss MJ
    J Med Chem; 1971 Apr; 14(4):331-5. PubMed ID: 5553746
    [No Abstract]   [Full Text] [Related]  

  • 3. Design, synthesis, and biological evaluation of oxindole derivatives as antidepressive agents.
    Suthar SK; Bansal S; Alam MM; Jaiswal V; Tiwari A; Chaudhary A; Alex AT; Joseph A
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5281-5. PubMed ID: 26428872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of inversion by demethylimipramine of motor depression induced by tetrabenazine].
    Lakoza GN
    Farmakol Toksikol; 1969; 32(4):406-10. PubMed ID: 5307899
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis, toxicological, and pharmacological assessment of derivatives of 2-aryl-4-(3-arylpropyl)morpholines.
    Avramova P; Danchev N; Buyukliev R; Bogoslovova T
    Arch Pharm (Weinheim); 1998 Nov; 331(11):342-6. PubMed ID: 9881056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological evaluation of some tetrahydrooxadiazinones and some dihydroaminooxadiazines.
    Trepanier DL; Eble JN; Harris GH
    J Med Chem; 1968 Mar; 11(2):357-60. PubMed ID: 5663629
    [No Abstract]   [Full Text] [Related]  

  • 7. New Human Monoamine Oxidase A Inhibitors with Potential Anti- Depressant Activity: Design, Synthesis, Biological Screening and Evaluation of Pharmacological Activity.
    Evranos-Aksoz B; Ucar G; Tas ST; Aksoz E; Yelekci K; Erikci A; Sara Y; Iskit AB
    Comb Chem High Throughput Screen; 2017; 20(6):461-473. PubMed ID: 28474547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibitors of monoamine oxidase. 2. Arylamide SAR.
    Harfenist M; Joyner CT; Mize PD; White HL
    J Med Chem; 1994 Jun; 37(13):2085-9. PubMed ID: 8027990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of monoamine oxidase by indole and benzofuran derivatives.
    Prins LH; Petzer JP; Malan SF
    Eur J Med Chem; 2010 Oct; 45(10):4458-66. PubMed ID: 20674099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the mechanism of action of the new antidepressant pyrazidol].
    Mashkovskiĭ MD; Gorkin VZ; Andreeva NI; Verevkina IV; Siniukhin VN
    Farmakol Toksikol; 1975; 38(5):531-6. PubMed ID: 1183581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newer formazans and tetrazolium indoles as potential CNS-active agents.
    Sathi G; Gujrati VR; Nath C; Agarwal JC; Bhargava KP; Shanker K
    Arzneimittelforschung; 1983; 33(9):1218-21. PubMed ID: 6685502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant activity of new hetero[2,1]benzothiazepine derivatives.
    Vega S; Diaz JA; Darias V; Sanchez Mateo CC; Albertos LM
    Pharmazie; 1998 Feb; 53(2):130-4. PubMed ID: 9540110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible therapeutic effect of T-794, a novel reversible inhibitor of monoamine oxidase-A, on post-stroke emotional disturbances, assessed in animal models of depression.
    Kato M; Iwata H; Katayama T; Asai H; Narita H; Endo T
    Biol Pharm Bull; 1997 Apr; 20(4):349-53. PubMed ID: 9145208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibitors of monoamine oxidase (MAO). 5. 1-Substituted phenoxathiin inhibitors containing no nitrogen that inhibit MAO A by binding it to a hydrophobic site.
    Harfenist M; McGee DP; Reeves MD; White HL
    J Med Chem; 1998 Jun; 41(12):2118-25. PubMed ID: 9622553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New indolyl peptidyl esters as MAO inhibitors.
    Sharma M; Gujrati VR; Nath C; Bhargava KP; Shanker K
    Pharmacol Res Commun; 1982 Oct; 14(9):827-37. PubMed ID: 7178212
    [No Abstract]   [Full Text] [Related]  

  • 16. 3-Indolylsuccinimides and 3-(3-pyrrolidinyl)indoles.
    Perron YG; Minor WF; Bierwagen ME; Ridlon SA; Pindell MH
    J Med Chem; 1966 Jan; 9(1):136-40. PubMed ID: 4381173
    [No Abstract]   [Full Text] [Related]  

  • 17. A study of antidepressant activity of some indole alkylamines.
    Sing KP; Gautam SK
    Arzneimittelforschung; 1977; 27(10):2002-5. PubMed ID: 21669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.
    Caille D; Bergis OE; Fankhauser C; Gardes A; Adam R; Charieras T; Grosset A; Rovei V; Jarreau FX
    J Pharmacol Exp Ther; 1996 Apr; 277(1):265-77. PubMed ID: 8613929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of a series of indole derivatives on monoamine oxidase activity].
    Pidevich IN; Krupinska I; Gryglewski R; Zhmuda A
    Farmakol Toksikol; 1971; 34(6):663-6. PubMed ID: 5139781
    [No Abstract]   [Full Text] [Related]  

  • 20. New quinolines as potential CNS agents.
    Sathi G; Gujrati VR; Sharma M; Nath C; Bhargava KP; Shanker K
    Arch Pharm (Weinheim); 1983 Sep; 316(9):767-72. PubMed ID: 6639304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.